IMAB

$0.00

(

0.00%

)
Quote details

stock

I-Mab

NASDAQ | IMAB

3.68

USD

$0.00

(

0.00%

)

At Close (As of Sep 15, 2025)

$333.99M

Market Cap

-

P/E Ratio

-0.51

EPS

$5.90

52 Week High

$0.59

52 Week Low

HEALTHCARE

Sector

IMAB Chart

Recent Chart
Price Action

IMAB Technicals

Tags:

IMAB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$375M
Selling General And Administrative $216M
Research And Development $159M
Operating Expenses $375M
Investment Income Net -
Net Interest Income $7.5M
Interest Income $7.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$363M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$375M
Ebitda -$373M
Net Income -$162M

Revenue & Profitability

Earnings Performance

IMAB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $213M
Total Current Assets $177M
Cash And Cash Equivalents At Carrying Value $68M
Cash And Short Term Investments $68M
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $36M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $31M
Short Term Investments $105M
Other Current Assets $2.1M
Other Non Current Assets -
Total Liabilities $12M
Total Current Liabilities $8.5M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $816K
Total Non Current Liabilities $3.1M
Capital Lease Obligations $3.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.9M
Other Current Liabilities $7.5M
Other Non Current Liabilities -
Total Shareholder Equity $201M
Treasury Stock -
Retained Earnings -$1.3B
Common Stock $19K
Common Stock Shares Outstanding $81M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$53M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $978K
Capital Expenditures $48K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$136M
Cashflow From Financing -$335K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$335K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$50M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$375M
Selling General And Administrative $216M
Research And Development $159M
Operating Expenses $375M
Investment Income Net -
Net Interest Income $7.5M
Interest Income $7.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$363M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$375M
Ebitda -$373M
Net Income -$162M

IMAB News

IMAB Profile

I-Mab Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

I-Mab, a clinical-stage biopharmaceutical company, discovers, develops and markets biologics to treat cancer and autoimmune disorders. The company is headquartered in Shanghai, the People's Republic of China.

ATCH
+162.84%
$1.02
GPUS
+28.83%
$0.47
CGBS
-39.47%
$0.03
BIAF
+30.48%
$0.35
BITF
+8.07%
$2.41
ATYR
-82.08%
$1.08
OPI
+65.26%
$0.91
CHEK
+245.90%
$2.58
TSLA
+5.42%
$417.40
NVDA
-0.19%
$177.48
SNAP
+1.56%
$7.45
NAKA
-51.44%
$1.34
GRAB
+1.50%
$6.09
YOSH
+65.11%
$2.13
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
INTC
+3.36%
$24.89
ADAP
+17.50%
$0.06
WBD
+1.49%
$19.15
AAL
-2.68%
$12.56
BINI
-17.14%
$0.06
MULN
-17.14%
$0.06
NXTT
-3.83%
$0.14
LYT
-16.77%
$0.09
RELI
+5.57%
$0.82
BTG
-2.33%
$4.38
NAOV
+74.73%
$11.34
NIO
+4.58%
$6.50
AIRE
-15.23%
$1.22
DNN
+4.13%
$2.46
RR
+14.15%
$3.74
SOUN
+2.33%
$14.45
MARA
-3.64%
$15.71
JOBY
+0.84%
$14.11
SOFI
+4.25%
$27.67
BBD
+2.55%
$3.21
RMBL
+60.50%
$3.21
MSN
+7.45%
$0.45
GOOGL
+3.53%
$249.30
PLUG
+1.97%
$1.55
ADD
-25.47%
$0.05
BMNR
-4.22%
$52.76
SRM
+53.27%
$10.30
BURU
-16.72%
$0.13
PLTR
-0.78%
$170.08
FRGT
+4.95%
$1.47
PFE
-0.16%
$23.82
ETHD
-10.88%
$3.03
CUTR
-10.19%
$0.09
ACHR
+3.71%
$9.07
PET
-59.91%
$0.04
ABEV
+2.17%
$2.35
ONFO
+17.25%
$1.32
QBTS
+1.26%
$17.98
WLGS
-5.57%
$0.04
ORCL
+2.35%
$299.06
CRWV
+6.89%
$119.68
RGTI
+0.83%
$19.25
RZLV
+12.72%
$7.62
ONDS
-3.42%
$6.33
AAPL
+0.83%
$236.02
IHT
+56.05%
$3.12
CIFR
-2.85%
$10.54
ETWO
0.00%
$3.30
HOOD
-0.23%
$114.76
RIG
+2.27%
$3.37
AMD
+1.10%
$160.33
TLRY
+2.75%
$1.15
F
+0.02%
$11.68
GLUE
+34.61%
$6.47
RIOT
+3.87%
$16.50
ORIS
+16.59%
$0.15
RAYA
+9.57%
$0.04
AIIO
+39.72%
$2.04
WULF
-5.23%
$10.19
SLNH
+25.56%
$0.89
QS
-0.85%
$9.86
IONQ
+5.84%
$58.86
PR
-3.39%
$13.23
AFMD
-34.94%
$0.18
IREN
+2.07%
$34.66
FAAS
-26.95%
$0.15
CAN
-0.86%
$0.81
AMZN
+1.55%
$231.70
APLD
+6.10%
$19.82
GPRO
+11.98%
$2.31
LDI
+3.93%
$4.43
BTE
-0.42%
$2.37
KEY
-1.15%
$18.84
KDLY
-29.53%
$2.78
HIMS
-1.88%
$54.45
KDP
-1.34%
$26.86
GRYP
-10.38%
$1.38
HSDT
+160.05%
$19.66
MODV
-25.22%
$0.43
YAAS
-8.59%
$0.07
GOOG
+3.25%
$249.24
HL
+4.32%
$11.69
ITUB
+3.22%
$7.19
RCEL
+43.31%
$6.53
ATCH
+162.84%
$1.02
GPUS
+28.83%
$0.47
CGBS
-39.47%
$0.03
BIAF
+30.48%
$0.35
BITF
+8.07%
$2.41
ATYR
-82.08%
$1.08
OPI
+65.26%
$0.91
CHEK
+245.90%
$2.58
TSLA
+5.42%
$417.40
NVDA
-0.19%
$177.48
SNAP
+1.56%
$7.45
NAKA
-51.44%
$1.34
GRAB
+1.50%
$6.09
YOSH
+65.11%
$2.13
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
INTC
+3.36%
$24.89
ADAP
+17.50%
$0.06
WBD
+1.49%
$19.15
AAL
-2.68%
$12.56
BINI
-17.14%
$0.06
MULN
-17.14%
$0.06
NXTT
-3.83%
$0.14
LYT
-16.77%
$0.09
RELI
+5.57%
$0.82
BTG
-2.33%
$4.38
NAOV
+74.73%
$11.34
NIO
+4.58%
$6.50
AIRE
-15.23%
$1.22
DNN
+4.13%
$2.46
RR
+14.15%
$3.74
SOUN
+2.33%
$14.45
MARA
-3.64%
$15.71
JOBY
+0.84%
$14.11
SOFI
+4.25%
$27.67
BBD
+2.55%
$3.21
RMBL
+60.50%
$3.21
MSN
+7.45%
$0.45
GOOGL
+3.53%
$249.30
PLUG
+1.97%
$1.55
ADD
-25.47%
$0.05
BMNR
-4.22%
$52.76
SRM
+53.27%
$10.30
BURU
-16.72%
$0.13
PLTR
-0.78%
$170.08
FRGT
+4.95%
$1.47
PFE
-0.16%
$23.82
ETHD
-10.88%
$3.03
CUTR
-10.19%
$0.09
ACHR
+3.71%
$9.07
PET
-59.91%
$0.04
ABEV
+2.17%
$2.35
ONFO
+17.25%
$1.32
QBTS
+1.26%
$17.98
WLGS
-5.57%
$0.04
ORCL
+2.35%
$299.06
CRWV
+6.89%
$119.68
RGTI
+0.83%
$19.25
RZLV
+12.72%
$7.62
ONDS
-3.42%
$6.33
AAPL
+0.83%
$236.02
IHT
+56.05%
$3.12
CIFR
-2.85%
$10.54
ETWO
0.00%
$3.30
HOOD
-0.23%
$114.76
RIG
+2.27%
$3.37
AMD
+1.10%
$160.33
TLRY
+2.75%
$1.15
F
+0.02%
$11.68
GLUE
+34.61%
$6.47
RIOT
+3.87%
$16.50
ORIS
+16.59%
$0.15
RAYA
+9.57%
$0.04
AIIO
+39.72%
$2.04
WULF
-5.23%
$10.19
SLNH
+25.56%
$0.89
QS
-0.85%
$9.86
IONQ
+5.84%
$58.86
PR
-3.39%
$13.23
AFMD
-34.94%
$0.18
IREN
+2.07%
$34.66
FAAS
-26.95%
$0.15
CAN
-0.86%
$0.81
AMZN
+1.55%
$231.70
APLD
+6.10%
$19.82
GPRO
+11.98%
$2.31
LDI
+3.93%
$4.43
BTE
-0.42%
$2.37
KEY
-1.15%
$18.84
KDLY
-29.53%
$2.78
HIMS
-1.88%
$54.45
KDP
-1.34%
$26.86
GRYP
-10.38%
$1.38
HSDT
+160.05%
$19.66
MODV
-25.22%
$0.43
YAAS
-8.59%
$0.07
GOOG
+3.25%
$249.24
HL
+4.32%
$11.69
ITUB
+3.22%
$7.19
RCEL
+43.31%
$6.53

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.